The heterochronic regulator
lin-14 affects certain somatic cell-fate choices during post-embryonic development in C. elegans . In
lin-14 mutants, cells express stage-specific developmental programs, such as cell divisions or dauer entry, at inappropriate times in development. 1,2 Loss-of-function mutations in
lin-14 result in the precocious execution of L2-specific programs during the first larval stage and the omission of L1-specific programs, while gain-of-function mutations retard the execution of L2-specific programs during the second larval stage and instead cause the re-iteration of L1-specific programs. We chose to study the molecular mechanisms of
lin-14 function using two complementary approaches. First, we characterized
lin-14 biochemically by analyzing its association with nuclei in vivo and by performing in vitro DNA binding assays. We also performed microarray analysis to identify genes misregulated under
lin-14 loss-of-function or gain-of-function conditions. We identified a number of genes whose transcript levels are regulated either positively or negatively by
lin-14 , and which could be among
lin-14 's in vivo targets. Using Northern blot and GFP-reporter fusion analysis we have begun to investigate whether these putatuve targets are transcriptionally controlled by
lin-14 , and whether this control is direct or indirect. The expression of one of these targets,
ins-33 , a C. elegans insulin homolog, appears to be controlled by
lin-14 at the level of transcription in vivo . LIN-14 protein can bind the
ins-33 promoter in vitro at at least two sites. We are currently characterizing the in vivo significance of these sites to
lin-14 dependent
ins-33 transcription. 1. Ambros, V., and H.R. Horvitz, Genes and Development (1987) 1:398 2. Liu, Z., and V. Ambros, Genes and Development (1989) 3:2039